Latest News about BMY
Recent news which mentions BMY
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
From Motley Fool
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
April 12, 2024
From Benzinga
Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024
April 12, 2024
From InvestorPlace
From InvestorPlace
From InvestorPlace
From Benzinga
From Motley Fool
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
From Motley Fool
Bristol Myers Squibb's Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation
April 08, 2024
From Benzinga
From Benzinga
Down 75%. Is Agenus Stock a Buy on the Dip?
April 08, 2024
From Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
April 05, 2024
From InvestorPlace
From Benzinga
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
April 03, 2024
From Motley Fool
From InvestorPlace
From InvestorPlace
From Benzinga
The 3 Best Biotech Stocks to Buy in Q2 2024
March 29, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
From Benzinga
From InvestorPlace
From Benzinga
Europe Approves Bristol Myers Squibb's CAR-T Therapy For Early Treatment Of Type Of Blood Cancer
March 21, 2024
From Benzinga
From Benzinga
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.